Loading...
XLON
EDEN
Market cap17mUSD
Dec 05, Last price  
2.40GBP
1D
0.00%
1Q
-22.58%
Jan 2017
-79.10%
IPO
-87.67%
Name

Eden Research PLC

Chart & Performance

D1W1MN
XLON:EDEN chart
P/E
P/S
2.98
EPS
Div Yield, %
Shrs. gr., 5y
20.66%
Rev. gr., 5y
18.71%
Revenues
4m
+34.79%
193,000172,00091,00043,59080,22399,855883,312391,9581,877,1872,774,2721,825,5011,368,9881,228,5801,827,1713,192,0274,302,603
Net income
-2m
L-70.64%
-1,727,000-3,251,000-3,284,000-2,317,134-1,587,909-2,969,468-1,157,103-1,831,092-639,093-334,951-1,144,703-2,270,347-2,788,973-2,237,262-6,494,249-1,906,591
CFO
-1m
L-40.51%
-432,000-1,751,000-2,628,000-1,621,505-1,245,977-930,295-104,861-805,789230,041-701,678-1,013,299-1,015,309-1,618,558-683,095-1,695,411-1,008,569

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, fragrances, deodorants, wound-care products, food flavorings, odor neutralizers, and active ingredient supply/delivery products. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.
IPO date
May 11, 2012
Employees
19
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT